The DOI matches its Crossref record, with a small difference in title or year; 49 of the 49 references it cites were found in a registry or an index.
Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
Open accessAbstract
SUMMARY: We investigated the production of IL-2, IFN-γ, IL-10 and IL-4 by PBMC from 24 patients with SLE and 10 healthy individuals. Basal and mitogen-stimulated (lipopolysaccharide and phytohaemagglutinin (LPS + PHA)) cytokine production was determined in a whole blood assay (WBA). Supernatants were collected and assayed with specific ELISAs. Although the IL-2 and IFN-γ contents did not differ significantly between patients and controls under both conditions, statistically significant correlations were found between each cytokine and disease activity (SLAM index) after stimulation (respectively, r= 0.501, P = 0.01 and r = 0.631, P = 0.001). PBMC IL-10 production was significantly higher for patients than controls (P = 0.05), but no correlation between IL-10 levels and the SLAM index was obtained. IL-4 production was not statistically different between SLE patients and controls. For stimulated WBAs, the IL-10/IL-2 and IL-10/IFN-γ ratios were significantly correlated with disease severity (P = 0.02; P = 0.001, respectively). Overall, our data suggest that SLE is characterized by an elevated production of IL-10, reflecting the basal state of activation of the immune system. During exacerbation of SLE, IL-2 and IFN-γ are synthesized in larger amounts and may cause the tissue damage observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In adaptative immune regulation, •NO inhibits the lymphocytes T helper 1 (Th1 is a population characterized by the release of IL-2 and IFN-γ) and promotes Th2 lymphocytes, which leads to humoral immunity and allergic responses [113].”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001303 · Cited by 1,332
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Cherwinski, H., Schumacher, J., Brown, K., & Mosmann, T. (1987) · Journal of Experimental Medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,118
Human TH1 and TH2 subsets: doubt no more
Romagnani, S. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90120-i · Cited by 1,079
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., & Shevach, E. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1224 · Cited by 829
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 787
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages
Gazzinelli, R. T., Oswald, I. P., James, S. L., & Sher, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1792 · Cited by 694
Llorente, L., Zou, W., Lévy, Y., Richaud‐Patín, Y., Wijdenes, J., Alcocer-Varela, J. C., Morel-Fourrier, B., Brouet, J. C., Alarcón-Segovia, D., Galanaud, P., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.839 · Cited by 540
Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E Production
Yoshimoto, T., Bendelac, A. S., Watson, L. C., Hu‐Li, J., & Paul, W. E. (1995) · Science · doi:10.1126/science.270.5243.1845 · Cited by 496
Groote, D. D., Zangerle, P. F., Gevaert, Y., Fassotte, M., Beguin, Y. P., Pirenne, F., Pirenne, J., Gathy, R., Lopez, M., Dehart, I., et al. (1992) · Cytokine · doi:10.1016/1043-4666(92)90062-v · Cited by 470
Linker‐Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S. J., Gillis, S. A., & Horwitz, D. A. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2651 · Cited by 453
Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110579 · Cited by 422
Chernoff, A., Granowitz, E. V., Shapiro, L., Vannier, E. G., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., & Dinarello, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5492 · Cited by 418
Jacob, C. O., van der Meide, P. H., & McDevitt, H. O. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.3.798 · Cited by 391
Towards a comprehensive view of immunoglobulin class switching
Snapper, C. M., & Mond, J. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90318-f · Cited by 375
Goldman, M., Druet, P., & Gleichmann, E. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90034-q · Cited by 360
Llorente, L., Richaud‐Patín, Y., Fior, R., Alcocer-Varela, J. C., Wijdenes, J., Fourrier, B. M., Galanaud, P., & Émilie, D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371114 · Cited by 312
Systemic autoimmune disease arises from polyclonal B cell activation.
Klinman, D. M., & Steinberg, A. D. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.165.6.1755 · Cited by 309
Hagiwara, E., Gourley, M. F., Lee, S., & Klinman, D. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390305 · Cited by 287
Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases
Al‐Janadi, M., Al-Balla, S. R., Al-Dalaan, A., & Raziuddin, S. (1993) · Journal of Clinical Immunology · doi:10.1007/bf00920636 · Cited by 261
Takahashi, S., Fossati, L., Iwamoto, M., Merino, R., Motta, R., Kobayakawa, T., & Izui, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118584 · Cited by 258
Llorente, L., Richaud‐Patín, Y., Wijdenes, J., Alcocer-Varela, J. C., Maillot, M. C., Durand–Gasselin, I., Fourrier, B. M., Galanaud, P., & Émilie, D. (1993) · PubMed · Cited by 203
Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity
Fowellf†, D., McKnight, A. J., Powrie, F. M., Dyke, R. V., & Mason, D. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00605.x · Cited by 171
Constitutive Expression of Interleukin (IL)-4 In Vivo Causes Autoimmune-type Disorders in Mice
Erb, K. J., Rüger, B. M., von Brevern, M., Ryffel, B., Schimpl, A., & Rivett, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.329 · Cited by 152
Davodeau, F., Peyrat, M., Necker, A., Dominici, R., Blanchard, F., Leget, C. J. W., Gaschet, J., Costa, P., Jacques, Y., Godard, A., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5603 · Cited by 134
Kallmann, B. A., Hüther, M., Tubes, M., Feldkamp, J., Bertrams, J., Gries, F. A., Lampeter, E. F., & Kolb, H. (1997) · Diabetes · doi:10.2337/diab.46.2.237 · Cited by 131
Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome
Santiago, M.-L., Fossati, L., Jacquet, C., Müller, W., Izui, S., & Reininger, L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.65 · Cited by 125
The proinflammatory cytokine response to coagulation and endotoxin in whole blood
Johnson, K., Aarden, L. A., Choi, Y., de Groot, E. R., & Creasey, A. A. (1996) · Blood · doi:10.1182/blood.v87.12.5051.bloodjournal87125051 · Cited by 114
Zangerle, P. F., Groote, D. D., Lopez, M., Meuleman, R. J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M. Y., Radoux, D., & Franchimont, P. (1992) · Cytokine · doi:10.1016/1043-4666(92)90021-i · Cited by 110
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 109
IL-8 gene expression and production in human peripheral blood lymphocyte subsets
Smyth, M. J., Zachariae, C. O. C., Norihisa, Y., Ortaldo, J. R., Hishinuma, A., & Matsushima, K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.11.3815 · Cited by 105
Deficient γ‐interferon production in patients with systemic lupus erythematosus
Tsokos, G. C., Boumpas, D. T., Smith, P. L., Djeu, J. Y., Balow, J. E., & Rook, A. H. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291005 · Cited by 63
Cytokine-based human whole blood assay for the detection of antigen-reactive T cells
Petrovsky, N., & Harrison, L. C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00127-v · Cited by 62
Rennick, D. M., Berg, D., & Holland, G. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90020-i · Cited by 57
Autocrine secretion and the physiological concentration of cytokines
Kaplan, D. R. (1996) · Immunology Today · doi:10.1016/0167-5699(96)30017-0 · Cited by 46
Swaak, A. J. G., van den Brink, H. G., & Aarden, L. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069992 · Cited by 39
Seder, R. A., Gros, G. S. L., Ben-Sasson, S. Z., Urban, J. F., Finkelman, F. D., & Paul, W. E. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210522 · Cited by 36
Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus
Faucal, P. D., Godard, A., Peyrat, M., Moreau, J., & Soulillou, J. P. (1984) · Annales de l Institut Pasteur Immunologie · doi:10.1016/s0769-2625(84)81108-3 · Cited by 30
Self-citationDräger, A. M., Swaak, A. J. G., van den Brink, H. G., & Aarden, L. A. (1986) · PubMed Central · Cited by 22
Claret, E. J., Renversez, J., Zheng, X., Bonnefoix, T., & Sotto, J. (1992) · Immunology Letters · doi:10.1016/0165-2478(92)90045-p · Cited by 21
Proliferation dependence and production of IL-2 in human alloreactive T-cell clones
Hallet, M., Peyrat, M., Moisan, J., Soulillou, J., & Moreau, J. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90114-7 · Cited by 7
Self-citationStatistical Analysis in Clinical Laboratory Medicine: Fundamentals and Common Uses
O’Brien, P. C., Shampo, M. A., Dyck, P. J., & Tilley, B. C. (1989) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368909105718 · Cited by 6
Research works printed but not linked: 5
- 10.1146/annurev.immunol.7.1.145 · DOI · Paper page
- Asherson RA, 1988, J Rheumatol, 15, 1742
- Llorente L, 1993, Eur Cytokine Netw, 4, 421
- 10.1146/annurev.immunol.11.1.165 · DOI
- Draeger AM, 1986, Clin Exp Immunol, 64, 80
Cited by
Sorted by citations
Wong, C. K., Lit, L. C. W., Tam, L., Li, E. K. M., Wong, P. T. Y., & Lam, C. W. K. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.019 · Cited by 535
Talaat, R. M., Mohamed, S. F., Bassyouni, I. H., & Raouf, A. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.027 · Cited by 494
Oxidative stress and human health
Rahman, T., Hosen, M. I., Islam, M. M., & Shekhar, H. U. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.327123 · Cited by 514
“Elevated levels of F2-isoprostane are associated with oxidant injury to tissue in a variety of disorders including ischemiareperfusion injury, atherosclerosis, diabetes and autoimmune disease [205,206].”
BackgroundWong, C. K., Ho, C. Y., Li, E. K., & Lam, C. (2000) · Lupus · doi:10.1191/096120300678828703 · Cited by 471
Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus
Chun, H.-Y., Chung, J.-W., Kim, H., Yun, J., Jeon, J., Ye, Y., Kim, S., Park, H., & Suh, C. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9104-0 · Cited by 390
“Concentrations of IFN-γ are increased in SLE patients, and the production of IFN-γ by PBMCs from SLE patients is significantly correlated with global disease activity [13, 29].”
Background
Metadata
- Authors
- VIALLARD, J. F., PELLEGRIN, J. L., RANCHIN, V, SCHAEVERBEKE, T., DEHAIS, J., LONGY-BOURSIER, M., RAGNAUD, J. M., LENG, B., & MOREAU, J. F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Laboratoire Immunotech, Marseille
- Hôpital Pellegrin (FR)
- Service de Médecine Interne, Hôpital Saint-André
- Corresponding author
- VIALLARD, J F
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01
- Volume
- 115
- Issue
- 1
- Pages
- 189-195
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- PMC
- PMC1905189
- OpenAlex
- W2030175762
- Cited by
- 247
- References
- 48
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 13 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 16 · 2013: 4 · 2012: 13
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical & Experimental Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- systemic lupus erythematosus, Th1/Th2 balance, interleukin-2, interferon-gamma, IL-10, IL-4, peripheral blood mononuclear cells, disease activity, cytokine ratios, immune activation, tissue damage
- MeSH terms
- Adolescent, Adult, Female, Humans, Interferon-gamma, Interleukin-2, Leukocytes, Mononuclear, Lupus Erythematosus, Systemic, Male, Middle Aged, Interleukin-4, Cytokines, Interleukin-10, Th1 Cells, Th2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
